Published June 30, 2023 | Version v1
Journal article Open

Cytokine Profile and Enzymes of Tubular Nephrothelium in the Urine of Children with Congenital Megaureter

Authors/Creators

  • 1. State Institution «Academician O. F. Vozianov Institute of Urology of NAMS of Ukraine», Ukraine
  • 2. State Institution «Academician O. F. Vozianov Institute of Urology of NAMS of Ukraine» , Ukraine

Description

The objective: to determine the concentration of transforming growth factor β1 (TGF-β1), interleukin 1β (IL-1β) and tumor necrosis factor-α (TNF-α), activity levels of tubular nephrothelium enzymes total N-acetyl-β-D-glucosaminidase (NAG), its thermostable NAG isoenzyme B (NAG-B), β-galactosidase (β-Gal), γ-glutamyl transpeptidase (GGT) and neutral α-glucosidase (Nα-Gl) as cytokine-enzymological risk criteria for the development of nephrofibrosis in the urine of children with congenital nonrefluxing megaureter (NRMU) and refluxing megaureter (RMU) with unilateral and bilateral localization of the pathological process.

Materials and methods. 174 patients with congenital MU were examined, who were divided into two groups. Group 1 included 131 children with NRMU, group 2 – 43 children with RMU aged from 6 months to 15 years. The control group included 25 practically healthy children.

There were 97 patients with unilateral NRMU (group 1a), with bilateral – 34 persons (group 1b); there were 16 patients with unilateral RMU (group 2a), with bilateral – 27 (group 2b). Cytokine and enzyme indicators were studied in the morning portion of urine before reconstructive treatment. The levels of cytokines were determined by the ELISA method. Enzyme activity of urine was determined by the colorimetric method.

Statistical processing of data was performed after analyzing the conformity of their distribution to the norm parameters.

Results. It was found that the levels of TGF-β1, IL-1β and TNF-α, as well as the activity levels of NAG, NAG-B, β-Gal, GGT and Nα-Gl in the urine of patients with both congenital NRMU and congenital RMU are significantly increased compared to similar indicators in the control group (p<0.001). In patients with congenital RMU, compared to similar average indicators of patients with congenital NRMU, there is a significant increase of all cytokine and enzyme parameters (р<0.05–0.001), which indicates the probability of ischemic-hypoxic, as well as fibrotic damages in the kidney parenchyma in children with MU, especially in patients with RMU.

A significant increase in the cytokine levels and enzyme activity levels were established in patients with NRMU and RMU with a unilateral process compared to similar control data (p<0.001. A statistically significant increase of TNF-α, the activity of NAG-B and β-Gal in patients with bilateral NRMU, the concentration of IL-1β, TNF-α and activity levels of NAG, NAG-B, β-Gal, GGT and Nα-Gl in patients with bilateral RMU compared with similar data in groups of patients with unilateral process was found (p<0.05–0.001).

Conclusions. Congenital MU (NRMU, RMU) negatively affects the function of the tubular nephrothelium, which is manifested by an increased level of profibrogenic cytokine TGF-β1 and pro-inflammatory cytokines IL-1β and TNF-α in the urine of children, as well as the activity levels of lysosomal enzymes NAG, NAG-B, β-Gal and brush border enzymes GGT and Nα-Gl, which have renal specific properties. This indicates a high probability of ischemic processes in the kidney parenchyma and the risk of nephrofibrosis development in these patients, especially in patients with RMU with bilateral localization of the pathological process.

Files

Cytokine_Profile_and_Enzymes_of_Tubular_Nephrothelium_in_the_Urine_of_Children_with_Congenital_Megaureter.pdf

Files (2.1 MB)

Additional details

References

  • Kushnirenko SV. Etiology of chronic illness in children. Urol. 2019;23(4):420–3. doi: 10.26641/2307-5279.23.4.2019.187217.
  • Digtyar VA, Kharitonyuk LM, Boyko MV, Obertinsky AV, Ostrovska OA, Shevchenko KV. Our treatment experience with children of the first fates of life from a megaureter. Urol. 2019;23(4):424–8. doi: 10.26641/2307-5279.23.4.2019.187226.
  • Golovkevich VV, Petersburg VF, Kalischuk OA, Myhal LYA, Nikulina GG, Serbina IE, Kalinina NA, Guivan GI. Differential tactics of treatment of non-reflexive megaureter in young children. Childhood Fad. 2014;(3-4):58–63.
  • Bachurin GV, Kolomoets YuS. Diagnostic and prognostic role of cytokines, interleukins and biomarkers of early kidney damage in patients with urolithiasis. Urol. 2019;90(3):237–42.
  • Deyuan Zhi, Meng Zhang, Jin Lin, Pei Liu, Meili Duan. GPR 120 Ameliorates apoptosis and inhibits the production of inflammatory cytokines in renal tubular epithelial cells. Inflammation. 2021;44:493–505. doi: 10.1007/s10753-020-01346-2.
  • Gupta S, Clarkson MR, Duggan J, Brady HR. Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int. 2000;58(4):1389–99. doi: 10.1046/j.1523-1755.2000.00301.x.
  • Lunyova GG, Kryvenko EO. Changes in the levels of pro-inflammatory cytokines (TNF-α, IL-1β and IL-17) and soluble adhesion molecules (VCFM-1 and E-selectin) in patients with chronic glomerulonephritis depending on the stage (II or III) of chronic kidney disease. Immunol Allergol: Scie Practice. 2011;(4):39–43.
  • Zaikova NM, Dlin VV, Sinitsyna LA, Korsunsky AA, Gatskan SH. Markers for determining the degree of fibrogenesis in children with vesicoureteral reflux. Pediatr. 2015;(3):45–51.
  • Mohkam M, Ghafari A. The Role of Urinary N-acetyl-beta-glucosaminidase in Diagnosis of Kidney Diseases. Ped Nephrol. 2015;3(3):84–91.
  • Melnyk AA. Diagnostic role of N-acetyl-β-D-glucosaminidase as an early marker of kidney damage. Kidneys. 2016;(4):37–47.
  • Nikulina HG, Myhal LYa, Petersburghskyi VF, Kalischuk OA, Serbina IE. Delineation of the degrees of ischemic damage of the kidney parenchyma in children with congenital vesicoureteral reflux (by enzymological criteria). Health Man 2022;(1-2):6–9.
  • Petersburgskyi VF, Drannik HM, Mygal LYa, Nikulina HG, Kalinina NA, Serbina IE, et al. Peculiarities of restoring the functional state of the kidney parenchyma in children with congenital defects of the ureterovesical segment depending on the methods of its surgical correction (according to cytokine-enzymological criteria). Health Man. 2021;(4):33–40.
  • Babintseva, A. Enzymaturia as a marker of renal dysfunction in full-term newborns with perinatal pathology. Kidneys. 2016;(4):17–23. doi: 10.22141/2307-1257.4.18.2016.84321.
  • Multbery B, Isaksson А. Enzyme immunoassay of β-hexosaminidase isoenzymes in human urine and renal cortex with monoclonal antibodies. Enzyme. 1989;42(1):25–30.
  • Bieniaś B, Sikora P. Potential Novel Biomarkers of Obstructive Nephropathy in Children with Hydronephrosis. Dis Markers. 2018;2018:1015726. doi: 10.1155/2018/1015726.
  • McLeod DJ, Sebastião YV, Ching CB, Greenberg JH, Furth SL, Becknell B. Longitudinal kidney injury biomarker trajectories in children with obstructive uropathy. Pediatr Nephrol. 2020;35(10):1907–14. doi: 10.1007/s00467-020-04602-7.
  • Lavrenchuk OV, Bagdasarova IV, Korol LV, Myhal LY. Biochemical predictors of the development of chronic kidney disease in children, convalescents of acute kidney damage. Zaporizhzhya Med J. 2021;23(1):65–71.
  • Lopez-Giacoman S, Madero M. Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J Nephrol. 2015;4(1):57–73. doi: 10.5527/wjn.v4.i1.57.
  • Bagdasarova IV, Myhal LYA, Fomina SP, Lavrenchuk OV, Korol LV, Dashchenko OO. Diagnostic value of lysosomal fermenturia in children with urinary tract infection: method. recommendations Ministry of Health of Ukraine, Academy of Medical Sciences of Ukraine, Ukrainian Center for Scientific Medical Information and Patent Licensing Work. Kyiv; 2009, p. 1–19.
  • Nikulina GG, Petersburg VF, Myhal LYa, Serbina IE, Kalischuk OA, inventors; State University «Institute of Urology of the National Academy of Sciences of Ukraine», patent holder. A method of assessing the effectiveness of restoring the functional state of the kidney parenchyma in children with congenital defects of the ureterovesical segment after ureterocystoneostomy. Ukrainian utility model patent No. 137073. 2019 Sep 25.
  • Myhal LYA, Nikulina GG, Serbina IE, Seimovsky DA, Petersburg VF, Kalischuk OA, inventors; State University «Institute of Urology of the National Academy of Sciences of Ukraine», patent holder. A method of assessing the degree of impairment of the functional state of the kidney parenchyma in children with congenital unilateral obstructive uronephropathy. Ukrainian utility model patent No. 75640. 2012 October 12.
  • Vozianov SO, Chernenko VV, Nikulina GG, Myhal LYA, Zheltovska NI, Chernenko DV, et al. Enzymological indicators of ischemic damage of the kidney parenchyma in patients with urolithiasis (Clinical-experimental study). Man Health. 2020;(3):42–5.
  • Bazalytska SV, Nikulina GG, Kordyum VA, Dubey IY, Vozianov SO, Romanenko AM, et al. Experimental therapy of chronic kidney ischemia using the drug of the main factor of growth of fibroblasts. Ukr J Nephrol Dialysis. 2022;(3):37–47.
  • Qiao X, Rao P, Zhang Y, Liu L, Pang M, Wang H, et al. Redirecting TGF-β Signaling through the β-Catenin/Foxo Complex Prevents Kidney Fibrosis. J Am Soc Nephrol. 2018;29(2):557–70. doi: 10.1681/ASN.2016121362.
  • Myhal LYA, Nikulina GG, Serbina IE, Seimivskyi DA, Petersburg VF. Diagnostic informativeness of enzymological indicators of lysosomal origin in the urine of children with congenital obstruction of the upper urinary tract. Lab Diagnostics. 2012;(3):15–9.